+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Efficacy of proton pump inhibitors for patients with duodenal ulcers: A pairwise and network meta-analysis of randomized controlled trials



Efficacy of proton pump inhibitors for patients with duodenal ulcers: A pairwise and network meta-analysis of randomized controlled trials



Saudi Journal of Gastroenterology 23(1): 11-19



To compare the efficacy and tolerance of different proton pump inhibitors (PPIs) in different doses for patients with duodenal ulcers. An electronic database was searched to collect all randomized clinical trials (RCTs), and a pairwise and network meta-analysis were performed. A total of 24 RCTs involving 6188 patients were included. The network meta-analysis showed that there were no significant differences for the 4-week healing rate of duodenal ulcer treated with different PPI regimens except pantoprazle 40 mg/d versus lansoprazole 15 mg/d [Relative risk (RR) = 3.57; 95% confidence interval (CI) = 1.36-10.31)] and lansoprazole 30 mg/d versus lansoprazole 15 mg/d (RR = 2.45; 95% CI = 1.01-6.14). In comparison with H2receptor antagonists (H2RA), pantoprazole 40 mg/d and lansoprazole 30 mg/d significantly increase the healing rate (RR = 2.96; 95% CI = 1.78-5.14 and RR = 2.04; 95% CI = 1.13-3.53, respectively). There was no significant difference for the rate of adverse events between different regimens, including H2RA for a duration of 4-week of follow up. There was no significant difference for the efficacy and tolerance between the ordinary doses of different PPIs with the exception of lansoprazle 15 mg/d.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 059668149

Download citation: RISBibTeXText

PMID: 28139495


Related references

Efficacy and Safety of Proton Pump Inhibitors in the Long-Term Aspirin Users: A Meta-Analysis of Randomized Controlled Trials. American Journal of Therapeutics 24(5): E559-E569, 2017

Vonoprazan versus proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: Protocol for meta-analysis of randomized controlled trials and observational studies. Medicine 98(8): E14381, 2019

Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials. Bmc Gastroenterology 2: 17, 2002

Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials. Critical Care 20(1): 120, 2016

Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clinical Gastroenterology and Hepatology 5(2): 178-85; Quiz 140, 2007

Proton pump inhibitors in the treatment of peptic ulcer bleeding A Cochrane Collaboration meta-analysis of randomized controlled Trials. American Journal of Gastroenterology 98(9 Suppl.): S49-S50, 2003

Intravenous proton pump inhibitors for peptic ulcer hemorrhage Meta-analysis of randomized controlled trials allowing endoscopic treatment. Gastroenterology 120(5 Suppl. 1): A 248, 2001

Proton pump inhibitors (PPI) in the treatment of peptic ulcer bleeding: a cochrane collaboration meta-analysis of randomized controlled trials (RCTS). American Journal of Gastroenterology 98: S49-S50, 2003

Proton pump inhibitors therapy and the risk of pneumonia: a systematic review and meta-analysis of randomized controlled trials and observational studies. Expert Opinion on Drug Safety 18(3): 163-172, 2019

Noninvasive Oxygenation Strategies in Immunocompromised Patients With Acute Hypoxemic Respiratory Failure: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials. Journal of Intensive Care Medicine 2019: 885066619844713, 2019

A Generalized Linear Modeling Framework for Pairwise and Network Meta-analysis of Randomized Controlled Trials. 2013

High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: a systematic review and meta-analysis of randomized controlled trials. Archives of Internal Medicine 170(9): 751-758, 2010

The efficacy and safety of dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a Bayesian network meta-analysis of 58 randomized controlled trials. Acta Diabetologica 56(3): 249-272, 2019

Safety and efficacy of miniaturized extracorporeal circulation when compared with off-pump and conventional coronary artery bypass grafting: evidence synthesis from a comprehensive Bayesian-framework network meta-analysis of 134 randomized controlled trials involving 22 778 patients. European Journal of Cardio-Thoracic Surgery 49(5): 1428-1440, 2016

Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in the treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials. Medicine 93(12): E64, 2014